Abeona Therapeutics Inc
Biotechnology
Healthcare
ABEO
48.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
4.26
52 week high
6.74
high
4.45
52 week low
4.09
low
3.93
growth
-0.23 %
previous Close
4.32
P/E ratio
market cap
248 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-30.27 M
-508.71 %
eps
0.00 %
-265.42 %
eps surprise
21.43 %
net profit margin
-3026900000.00 %
0.00 %
operating incoming
-15.35 M
14.10 %
net change in cash
-18.70 M
-210.86 %
cash on hand
15.73 M
-54.32 %
cost of revenue
0.00 %
top top